Oyster Point Pharma, Inc. Operating Lease Liability
Oyster Point Pharma, Inc. had Operating Lease Liability of $2.47 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2022-11-10
- 2022-09-30: Operating Lease, Liability $2.47M.
- 2022-06-30: Operating Lease, Liability $2.65M.
- 2022-03-31: Operating Lease, Liability $2.66M.
- 2021-12-31: Operating Lease, Liability $2.89M.
| Period end | Operating Lease, Liability |
|---|---|
| 2022-09-30 | $2.47M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $2.65M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $2.66M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $2.89M 10-K · filed 2022-02-24 |
| 2021-09-30 | $636.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $764.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $888.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $650.00K 10-K · filed 2021-02-18 |
| 2020-09-30 | $744.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $836.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $926.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $808.00K 10-K · filed 2020-02-27 |
| 2019-09-30 | $882.00K 10-Q · filed 2019-12-03 |
| 2018-12-31 | $62.00K 10-K · filed 2020-02-27 |